We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




All-in-One Test Provides Faster Testing for Persistent Diarrhea

By LabMedica International staff writers
Posted on 18 Apr 2017
Print article
Image: The IBcause kit comes with everything needed for private stool sample collection (Photo courtesy of Prometheus Laboratories).
Image: The IBcause kit comes with everything needed for private stool sample collection (Photo courtesy of Prometheus Laboratories).
A convenient new multiplex diagnostic assay evaluates a unique combination of 20 stool and blood serum measures all at once, assisting healthcare providers to more rapidly test for many common causes of persistent diarrhea, compared to sequential testing with standard workup for persistent diarrhea.

Current methods of identifying the underlying cause(s) of persistent diarrhea can be slow, time-consuming, and frustrating. To help more quickly and effectively diagnose the cause(s) of a patient’s ongoing diarrhea (which may be referred to as persistent or chronic), Prometheus Laboratories (San Diego, CA, USA), of Nestlé Health Science (Epalinges, Switzerland), has launch their new assay “IBcause.”

"IBcause may help healthcare providers get to a diagnosis faster and a specific treatment plan sooner than sequential testing and empiric treatment for persistent diarrhea," said Warren Cresswell, Prometheus Diagnostics (Dx), "IBcause brings many key stool and serum assays together, including a proprietary assay that is not available elsewhere in the United States to test for bile acid malabsorption (BAM). BAM may affect up to 50% of patients with unexplained persistent diarrhea and is often overlooked or misdiagnosed as diarrhea-predominant irritable bowel syndrome (IBS-D)."

As part of patient support, new resources have been developed, including a guide, videos, a website, and telephone support to address patient questions. A convenient online portal, PrometheusOnline.com, for obtaining fast test results and information for patients, as well as test ordering and results for healthcare providers, is also available.

New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HbA1c Test
HbA1c Rapid Test
New
Benchtop Cooler
PCR-Cooler & PCR-Rack

Print article

Channels

Molecular Diagnostics

view channel
Image: Health Canada has approved SPINEstat, a first-in-class diagnostic blood test for axSpA, as a Class II medical device (Photo courtesy of Augurex)

First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.